Reuters logo
REFILE-TABLE-Sawai Pharmaceutical-2016/17 group results
May 15, 2017 / 7:19 AM / 4 months ago

REFILE-TABLE-Sawai Pharmaceutical-2016/17 group results

 (Adds company forecast. Accounting policy for forecast is IFRS)
May 15 (Reuters)- 
Sawai Pharmaceutical Co Ltd 
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT
                Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR
                   LATEST         YEAR-AGO        COMPANY      COMPANY
                   RESULTS         RESULTS       FORECAST    H1 FORECAST
  Sales            132.43          123.49          142.00
                 (+7.2 pct)      (+17.1 pct)
  Operating         20.63           23.19           24.20
                 (-11.0 pct)     (+12.1 pct)
  Recurring         20.56           23.03           23.80
                 (-10.7 pct)     (+11.7 pct)
  Net               15.91           17.16           18.20
                 (-7.2 pct)      (+22.1 pct)
  EPS            431.65 yen      465.57 yen     493.65 yen
  EPS Diluted    431.39 yen      465.25 yen
  Ann Div        130.00 yen      120.00 yen     130.00 yen
  -Q2 Div         65.00 yen       55.00 yen      65.00 yen
  -Q4 Div         65.00 yen       65.00 yen      65.00 yen
NOTE - Sawai Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T  

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below